Sertraline and Almotriptan: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Almotriptan
No brand names on recordSertraline
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines raise serotonin, a chemical in your brain and body. Almotriptan is a migraine medicine, and sertraline is an antidepressant. When you take them together, the extra serotonin can, in rare cases, build up too much and cause a reaction called serotonin syndrome.
Watch for things like feeling restless or shaky, a fast heartbeat, sweating, muscle twitching, high fever, or an upset stomach. This is uncommon, and many people take these two together safely. Your care team can manage it by watching you more closely, especially when you first start or when a dose goes up. If you notice those symptoms, call your doctor or pharmacist right away.
Interaction: Additive serotonergic effects (triptan 5-HT agonist + SSRI) may increase risk of serotonin syndrome. This is a pharmacodynamic interaction, not a metabolic/prodrug one; neither drug's activation is at issue here.
- Direction: Increased serotonergic tone (additive effect).
- Onset: Delayed.
- Evidence: Theoretical; observed risk ~0 to 4 cases per 10,000 person-years of combined triptan + SSRI/SNRI exposure.
- Monitoring: Watch for hyperthermia, autonomic instability, clonus, hyperreflexia, agitation, and GI symptoms, especially at initiation and dose titration.
Coadministration is acceptable with vigilance; dose may be individualized by the care team.
What happens
An increased risk of serotonin syndrome
Interaction Deep Dive
Serotonin syndrome, which can be life-threatening, has been documented when a 5-hydroxytryptamine receptor agonist (triptan) such as almotriptan is given together with an SSRI 3. Over a 14-year period, one study evaluated patients who were coprescribed triptans alongside SSRI or serotonin norepinephrine reuptake inhibitor (SNRI) antidepressants and found the risk of serotonin syndrome from combined use to range from 0 to 4 cases per 10,000 person-years of exposure 2. Clinical features may involve restlessness, hallucinations, impaired coordination, rapid heartbeat, quick fluctuations in blood pressure, elevated body temperature, hyperactive reflexes, nausea, vomiting, and diarrhea 1. When these agents are used together, close monitoring is recommended, particularly at the start of therapy and when doses are raised 3.
Why it happens (mechanism)
Additive pharmacologic effects resulting in excessive serotonergic stimulation
How to manage this interaction
Good news: many people use a triptan and an SSRI together safely, and your care team can manage this by keeping a closer eye on you, especially when either medicine is started or a dose is raised.
- Keep taking both as prescribed unless your doctor tells you otherwise.
- Learn the warning signs: restlessness, confusion or hallucinations, poor coordination, fast heartbeat, blood pressure swings, fever, twitchy or overactive reflexes, nausea, vomiting, or diarrhea.
- Tell your care team if these appear, and get urgent help if several come on together.
Ask your pharmacist or prescriber before any dose change, and mention all other serotonin-raising medicines you take.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
2 reports — tap to read
a) In a 14 year study of patients who were coprescribed 5-hydroxytryptamine receptor agonists (triptans) together with SSRI or serotonin norepinephrine reuptake inhibitor (SNRI) antidepressants (n=19,017; total exposure=30,928 person-years), the risk of serotonin syndrome with concurrent use was found to be 0 to 4 cases per 10,000 person-years of exposure. When only confirmed cases were counted (n=2) and when confirmed cases plus possible cases were counted (n=7), the risk of serotonin syndrome with concurrent use was 0.6 (95% CI, 0 to 1.5) and 2.3 (95% CI, 0.6 to 3.9) cases per 10,000 person-years of exposure, respectively. Over the course of the study, an average of 26% (range, 21% to 29%) of patients were given triptan prescriptions, including sumatriptan, zolmitriptan, naratriptan, rizatriptan, eletriptan, almotriptan, or frovatriptan, along with a coprescribed SSRI or SNRI antidepressant, including citalopram, fluvoxamine, escitalopram, paroxetine, fluoxetine, sertraline, duloxetine, or venlafaxine 2.
b) Giving fluoxetine and almotriptan together is well tolerated, and fluoxetine produces only a modest effect on almotriptan maximum plasma concentration (Cmax). The remaining almotriptan pharmacokinetics are not significantly altered. A randomized, open-label, two-way crossover study with 14 healthy volunteers was performed. Participants received each of the following regimens with at least a 3-week washout between periods: (1) three 20 mg fluoxetine capsules on days 1 to 8 and a single 12.5 mg almotriptan dose on day 8, (2) a single 12.5 mg almotriptan dose on day 8 with no treatment on days 1 through 7. Peak almotriptan concentrations were 18% higher when fluoxetine was given concurrently than when almotriptan was given alone. This difference reached statistical significance (p equal 0.023). Mean almotriptan area under the concentration-time curve (AUC) and oral clearance were borderline statistically different between the treatment groups. Mean half-life was not statistically different between the treatment groups. When fluoxetine was coadministered, Tmax was shorter, indicating that fluoxetine may have increased the absorption rate of almotriptan. The author concludes that, based on this study's results and the absence of an effect of fluoxetine on almotriptan pharmacokinetics, almotriptan and fluoxetine can be used together safely in the management of migraine 4.
Common questions
Can I take Sertraline and Almotriptan together?
Taking almotriptan with sertraline can slightly raise the risk of serotonin syndrome, so watch for symptoms like agitation, fast heartbeat, fever, or shakiness, especially when starting or increasing a dose, and report them promptly. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Almotriptan interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Sertraline and Almotriptan interaction managed?
Good news: many people use a triptan and an SSRI together safely, and your care team can manage this by keeping a closer eye on you, especially when either medicine is started or a dose is raised. Keep taking both as prescribed unless your doctor tells you otherwise. Learn the warning signs: restlessness, confusion or hallucinations, poor coordination, fast heartbeat, blood pressure swings, fever,… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Almotriptan need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- US Food and Drug Administration: 5-Hydroxytryptamine Receptor Agonists (Triptans) Selective Serotonin Reuptake Inhibitors (SSRIs) Selective Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs) Serotonin Syndrome. US Food and Drug Administration. Rockville, MDAvailable from URL:
- Orlova Y, Rizzoli P, & Loder E: Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants with serotonin syndrome. JAMA Neurol 2018; 75(5):566-572. PubMed
- Product Information: AXERT(R) oral tablets, almotriptan malate oral tablets. Janssen Pharmaceuticals, Inc. (per FDA), Titusville, NJ, 2017. DailyMed
- Fleishaker J, Ryan K, Carel B, et al: Evaluation of the potential pharmacokinetic interaction between almotriptan and fluoxetine in healthy volunteers. J Clin Pharmacol 2001; 41:217-223. PubMed
Keep reading about Almotriptan
Keep reading about Sertraline
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist